Literature DB >> 18940884

Complement deposition in renal histopathology of patients with ANCA-associated pauci-immune glomerulonephritis.

Min Chen1, Guang-Qun Xing, Feng Yu, Gang Liu, Ming-Hui Zhao.   

Abstract

BACKGROUND: The pathogenesis of ANCA-associated pauci-immune glomerulonephritis has not been fully elucidated. Several studies had suggested that complement deposition could be detected in renal histopathology. The current study investigated the clinical and pathological significance of complement deposition in renal histopathology of patients with ANCA-associated pauci-immune glomerulonephritis.
METHODS: Renal biopsy specimens from 112 patients with ANCA-associated pauci-immune glomerulonephritis were investigated using direct immunofluorescence, light and electron microscopy. For direct immunofluorescence, IgG, IgA, IgM, C3c and C1q staining on fresh frozen renal tissue were routinely performed immediately after a renal biopsy. Complement deposition was defined as the presence of C3c or C1q for at least 1+ in a 0-4+ scale. Clinical and histopathological data between patients with and without complement deposition were compared.
RESULTS: In direct immunofluorescence microscopy, C3c and C1q could be detected in glomerular capillary wall and/or mesangium in the specimens of 37/112 (33.0%), 7/112 (6.3%) patients, respectively. Compared with patients without C3c deposition, patients with C3c deposition had a higher level of urinary protein (P < 0.01) and poorer initial renal function (P < 0.05).
CONCLUSION: Complement deposition was not rare in renal histopathology of human ANCA-associated pauci-immune glomerulonephritis, which was associated with more severe renal injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18940884     DOI: 10.1093/ndt/gfn586

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  42 in total

Review 1.  ANCA-associated vasculitides--advances in pathogenesis and treatment.

Authors:  Min Chen; Cees G M Kallenberg
Journal:  Nat Rev Rheumatol       Date:  2010-10-05       Impact factor: 20.543

2.  With complements from ANCA mice.

Authors:  Ralph Kettritz
Journal:  J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 10.121

Review 3.  Review: Complement and its regulatory proteins in kidney diseases.

Authors:  Allison M Lesher; Wen-Chao Song
Journal:  Nephrology (Carlton)       Date:  2010-10       Impact factor: 2.506

Review 4.  Complement blockade in ANCA-associated vasculitis: an index case, current concepts and future perspectives.

Authors:  Lucio Manenti; Maria Letizia Urban; Federica Maritati; Maricla Galetti; Augusto Vaglio
Journal:  Intern Emerg Med       Date:  2017-02-13       Impact factor: 3.397

Review 5.  Complement in ANCA-associated vasculitis: mechanisms and implications for management.

Authors:  Min Chen; David R W Jayne; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2017-03-20       Impact factor: 28.314

Review 6.  Complement in antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Jun Yuan; Min Chen; Ming-Hui Zhao
Journal:  Clin Exp Nephrol       Date:  2012-11-23       Impact factor: 2.801

7.  Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN.

Authors:  Shen-Ju Gou; Jun Yuan; Chen Wang; Ming-Hui Zhao; Min Chen
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 8.237

8.  Complement regulatory proteins in kidneys of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.

Authors:  L Cheng; S-J Gou; H-Y Qiu; L Ma; P Fu
Journal:  Clin Exp Immunol       Date:  2017-10-20       Impact factor: 4.330

9.  Circulating C3 levels predict renal and global outcome in patients with renal vasculitis.

Authors:  Javier Villacorta; Francisco Diaz-Crespo; Mercedes Acevedo; Teresa Cavero; Carmen Guerrero; Manuel Praga; Gema Fernandez-Juarez
Journal:  Clin Rheumatol       Date:  2016-08-25       Impact factor: 2.980

Review 10.  Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis.

Authors:  J Charles Jennette; Ronald J Falk; Peiqi Hu; Hong Xiao
Journal:  Annu Rev Pathol       Date:  2013-01-24       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.